Related Experiment Video
Updated: Jul 16, 2026
08:56
Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
GFP-transgenic Lewis rats as a cell source for oligodendrocyte replacement
Jeremy S Francis1, Ana Olariu, Eiji Kobayashi
1Cell and Gene Therapy Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 401 Haddon Ave., E and R Building Room 390, Camden, NJ 08103, USA.
Experimental Neurology
|March 27, 2007
Summary
We found that cells from young GFP-transgenic rats can effectively generate new oligodendrocytes. These cells successfully replaced damaged cells in rat models of white matter disease, showing promise for future therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Oligodendrocytes are crucial for myelin maintenance in the central nervous system (CNS).
- White matter diseases and injuries lead to oligodendrocyte loss and demyelination.
- Developing effective cell replacement strategies is vital for treating these conditions.
Purpose of the Study:
- To investigate the gliogenic potential of cells from a Green Fluorescent Protein (GFP)-transgenic rat.
- To assess the suitability of these cells for oligodendrocyte replacement in demyelinating disease models.
- To characterize the differentiation and integration of transplanted cells.
Main Methods:
- Isolation and culture of sphere-forming cells from postnatal GFP-transgenic rat brains.
- In vitro differentiation of cells into oligodendrocytes, confirmed by GFP expression and mature oligodendrocyte markers.
- Transplantation of GFP-positive cells into ethidium bromide-induced white matter lesions in recipient rats.
Main Results:
- Postnatal-derived cells showed significantly higher gliogenic potential (>50% differentiation) compared to embryonic cells.
- Differentiated oligodendrocytes displayed enhanced GFP fluorescence and expressed mature oligodendrocyte markers.
- Transplanted cells engrafted and survived in host white matter and cerebral cortex for at least 6 weeks.
Conclusions:
- Sphere-forming cultures from early postnatal GFP-transgenic rat brains are a valuable source for oligodendrocyte generation.
- These cells demonstrate potential for oligodendrocyte replacement therapy in white matter disorders.
- The study provides a robust model for investigating cell-based strategies for CNS repair.
